Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

69.9K
Overview
69.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
Selectins01:25

Selectins

3.2K
Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Antimicrobial Proteins01:23

Antimicrobial Proteins

732
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
732
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.3K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades.

Cancer genomics & proteomics·2026
Same author

Skimmianine Pretreatment Attenuates Cerebellar Neuroinflammation and Myelin Injury Following Experimental Cerebral Ischemia-Reperfusion.

Antioxidants (Basel, Switzerland)·2026
Same author

Proximity Mapping of the ER Proteome Reveals Metastasis-specific Candidate Biomarkers in Breast Cancer Cell Lines.

Cancer genomics & proteomics·2026
Same author

Boron neutron capture therapy (BNCT) for experimental bladder cancer: systemic or intravesical approach.

British journal of cancer·2026
Same author

Predictive factors for stone-free rates and evaluation of mucosal injury using PULS grading system in pediatric ureteroscopy: a single-center experience.

Urolithiasis·2026
Same author

Altered Endocannabinoid Signaling in Placentas from SARS-CoV-2-Infected Pregnancies.

Diagnostics (Basel, Switzerland)·2026
Same journal

Correction: Iliuta et al. Impact of Pulmonary Hypertension on Mortality After Surgery for Aortic Stenosis. <i>Medicina</i> 2022, <i>58</i>, 1231.

Medicina (Kaunas, Lithuania)·2026
Same journal

Prognostic Value of BUN-Based Ratios for Mortality and Prolonged Hospitalization in Acute Upper Gastrointestinal Bleeding: Comparison with Established Risk Scores.

Medicina (Kaunas, Lithuania)·2026
Same journal

One-Year Comparative Outcomes of Conventional Versus Accelerated Corneal Cross-Linking in Progressive Keratoconus.

Medicina (Kaunas, Lithuania)·2026
Same journal

Beyond the Intestinal Mucosa in Long-Standing Inflammatory Bowel Disease: Consequences of Chronic Inflammation and Endoscopic Approaches to Diagnosis and Management.

Medicina (Kaunas, Lithuania)·2026
Same journal

Biological and Metabolic Correlates of Psychological Resilience in Maintenance Hemodialysis: An Exploratory Gender-Based Study.

Medicina (Kaunas, Lithuania)·2026
Same journal

Influence of Mitral Annular Calcification Assessed by Cardiac Computed Tomography on Procedural and Clinical Outcomes of Transcatheter Aortic Valve Implantation.

Medicina (Kaunas, Lithuania)·2026
See all related articles

Related Experiment Video

Updated: May 10, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.2K

Proteomic and In Silico Analyses Highlight Complement System's Role in Bladder Cancer Immune Regulation.

Tuğcan Korak1, İbrahim Halil Baloğlu2, Murat Kasap1

  • 1Department of Medical Biology, Faculty of Medicine, Kocaeli University, Kocaeli 41001, Türkiye.

Medicina (Kaunas, Lithuania)
|April 26, 2025
PubMed
Summary
This summary is machine-generated.

This study identifies key complement system proteins, including CFI, C4A, and C4B, as potential biomarkers for bladder cancer (BLCA) immunotherapy, aiming to improve patient survival and treatment outcomes.

Keywords:
bladder cancercomplement systemprognosisproteomicstumor immune microenvironment

More Related Videos

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

5.9K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

14.6K

Related Experiment Videos

Last Updated: May 10, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.2K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

5.9K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

14.6K

Area of Science:

  • Immunology
  • Oncology
  • Proteomics

Background:

  • Bladder cancer (BLCA) presents a significant health burden with high recurrence and limited treatment efficacy.
  • Current immunotherapies for BLCA face challenges due to a lack of reliable therapeutic targets.
  • Understanding immune-related biomarkers is crucial for improving BLCA tumor microenvironment modulation.

Purpose of the Study:

  • To investigate potential immune-related biomarkers influencing the bladder cancer tumor microenvironment.
  • To identify novel therapeutic targets for enhancing BLCA immunotherapy effectiveness.

Main Methods:

  • Proteomic analysis using liquid chromatography/mass spectrometry (LC-MS)/MS on BLCA patient and control samples.
  • In silico approaches including protein network analysis (Cytoscape) and functional annotation (Enrichr).
  • Immunological analysis and prognostic evaluation using Sangerbox and Kaplan-Meier Plotter.

Main Results:

  • Identified 120 differentially regulated immune-related proteins, with the complement cascade significantly enriched.
  • Key complement system proteins (C4A, CFB, C4B, C8B, CFH, CFI, C5, C4BPA, C3, C2) were identified.
  • Four hub genes (CFB, C4B, CFI, C2) showed significant prognostic value for BLCA, correlating with immune infiltration and checkpoint genes.

Conclusions:

  • The complement system plays a pivotal role in the immune regulation of bladder cancer.
  • CFI, C4A, and C4B are identified as potential therapeutic targets for BLCA immunotherapy.
  • Targeting these proteins may enhance survival and improve outcomes for bladder cancer patients.